Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia
ABSTRACT This investigation evaluated the reliability and validity of the 6‐Minute Walk Test (6MWT) in patients with pediatric hypophosphatasia (HPP). Children (aged 6 to 12 years; n = 11), adolescents (13 to 17 years; n = 4), and adults (18 to 65 years; n = 9) completed the 6MWT at screening and ba...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | JBMR Plus |
Subjects: | |
Online Access: | https://doi.org/10.1002/jbm4.10131 |
id |
doaj-c01abcbd223a479086ae856f06803a45 |
---|---|
record_format |
Article |
spelling |
doaj-c01abcbd223a479086ae856f06803a452021-05-02T15:13:40ZengWileyJBMR Plus2473-40392019-06-0136n/an/a10.1002/jbm4.10131Reliability and Validity of the 6‐Minute Walk Test in HypophosphatasiaDawn Phillips0Ioannis C Tomazos1Scott Moseley2Gil L'Italien3Hugo Gomes da Silva4Sergio Lerma Lara5Division of Physical TherapyDepartment of Allied Health SciencesUniversity of North CarolinaChapel HillNCUSAAlexion Pharmaceuticals, Inc.BostonMAUSAAlexion Pharmaceuticals, Inc.BostonMAUSAAlexion Pharmaceuticals, Inc.BostonMAUSAAlexion Pharmaceuticals, Inc.BostonMAUSACentro Superior de Estudios Universitarios (CSEU) La SalleUniversidad Autónoma de MadridMadridSpainABSTRACT This investigation evaluated the reliability and validity of the 6‐Minute Walk Test (6MWT) in patients with pediatric hypophosphatasia (HPP). Children (aged 6 to 12 years; n = 11), adolescents (13 to 17 years; n = 4), and adults (18 to 65 years; n = 9) completed the 6MWT at screening and baseline in two clinical studies of asfotase alfa. Test‐retest reliability of the 6MWT, evaluated with Pearson's correlation coefficients (r) for screening versus baseline, was high for children (r = 0.95; p < 0.0001), adolescents (r = 0.81; p = 0.125), and adults (r = 0.94; p = 0.0001). The most conservative minimal clinically important differences, estimated using distribution‐based methods, were 31 m (children and adults) and 43 m (adolescents). In children, the 6MWT correlated significantly with scores on measures of skeletal disease, which included the Radiographic Global Impression of Change scale (r = 0.50; p < 0.0001) and the Rickets Severity Scale (r = −0.78; p < 0.0001), such that distance walked increased as the severity of skeletal disease decreased. Significant (p < 0.0001) correlations with the 6MWT distance walked were also observed for children with scores on parent‐reported measures of disability (r = −0.67), ability to function in activities of daily living (r = 0.71 to 0.77), and parent‐reported measures of pain (r = −0.39). In adolescents and adults, 6MWT distance walked correlated significantly (p < 0.05) with measures of lower extremity function (r = 0.83 and 0.60, respectively), total pain severity (r = −0.41 and −0.36, respectively), and total pain interference (r = −0.41 and −0.49, respectively). Collectively, these data indicate that the 6MWT is a reliable, valid measure of physical functioning in patients with pediatric HPP. © 2018 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.https://doi.org/10.1002/jbm4.10131BONE DISEASESMETABOLICQUALITY OF LIFEAMBULATIONVALIDATION STUDIESMINIMAL CLINICALLY IMPORTANT DIFFERENCE |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dawn Phillips Ioannis C Tomazos Scott Moseley Gil L'Italien Hugo Gomes da Silva Sergio Lerma Lara |
spellingShingle |
Dawn Phillips Ioannis C Tomazos Scott Moseley Gil L'Italien Hugo Gomes da Silva Sergio Lerma Lara Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia JBMR Plus BONE DISEASES METABOLIC QUALITY OF LIFE AMBULATION VALIDATION STUDIES MINIMAL CLINICALLY IMPORTANT DIFFERENCE |
author_facet |
Dawn Phillips Ioannis C Tomazos Scott Moseley Gil L'Italien Hugo Gomes da Silva Sergio Lerma Lara |
author_sort |
Dawn Phillips |
title |
Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia |
title_short |
Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia |
title_full |
Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia |
title_fullStr |
Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia |
title_full_unstemmed |
Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia |
title_sort |
reliability and validity of the 6‐minute walk test in hypophosphatasia |
publisher |
Wiley |
series |
JBMR Plus |
issn |
2473-4039 |
publishDate |
2019-06-01 |
description |
ABSTRACT This investigation evaluated the reliability and validity of the 6‐Minute Walk Test (6MWT) in patients with pediatric hypophosphatasia (HPP). Children (aged 6 to 12 years; n = 11), adolescents (13 to 17 years; n = 4), and adults (18 to 65 years; n = 9) completed the 6MWT at screening and baseline in two clinical studies of asfotase alfa. Test‐retest reliability of the 6MWT, evaluated with Pearson's correlation coefficients (r) for screening versus baseline, was high for children (r = 0.95; p < 0.0001), adolescents (r = 0.81; p = 0.125), and adults (r = 0.94; p = 0.0001). The most conservative minimal clinically important differences, estimated using distribution‐based methods, were 31 m (children and adults) and 43 m (adolescents). In children, the 6MWT correlated significantly with scores on measures of skeletal disease, which included the Radiographic Global Impression of Change scale (r = 0.50; p < 0.0001) and the Rickets Severity Scale (r = −0.78; p < 0.0001), such that distance walked increased as the severity of skeletal disease decreased. Significant (p < 0.0001) correlations with the 6MWT distance walked were also observed for children with scores on parent‐reported measures of disability (r = −0.67), ability to function in activities of daily living (r = 0.71 to 0.77), and parent‐reported measures of pain (r = −0.39). In adolescents and adults, 6MWT distance walked correlated significantly (p < 0.05) with measures of lower extremity function (r = 0.83 and 0.60, respectively), total pain severity (r = −0.41 and −0.36, respectively), and total pain interference (r = −0.41 and −0.49, respectively). Collectively, these data indicate that the 6MWT is a reliable, valid measure of physical functioning in patients with pediatric HPP. © 2018 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research. |
topic |
BONE DISEASES METABOLIC QUALITY OF LIFE AMBULATION VALIDATION STUDIES MINIMAL CLINICALLY IMPORTANT DIFFERENCE |
url |
https://doi.org/10.1002/jbm4.10131 |
work_keys_str_mv |
AT dawnphillips reliabilityandvalidityofthe6minutewalktestinhypophosphatasia AT ioannisctomazos reliabilityandvalidityofthe6minutewalktestinhypophosphatasia AT scottmoseley reliabilityandvalidityofthe6minutewalktestinhypophosphatasia AT gillitalien reliabilityandvalidityofthe6minutewalktestinhypophosphatasia AT hugogomesdasilva reliabilityandvalidityofthe6minutewalktestinhypophosphatasia AT sergiolermalara reliabilityandvalidityofthe6minutewalktestinhypophosphatasia |
_version_ |
1721490339816013824 |